Being A Star In Your Industry Is A Matter Of Xarelto Lawsuit

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical businesses, including the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to perform so could be grounds for compensation. Our lawyers are working difficult to acquire these hurt by the drug the compensation they're entitled to.

While bleeding is really a typical complication connected with anticoagulants, it has been alleged that Xarelto is far more hazardous than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the occasion of an emergency, sufferers may possibly be at danger for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.

Should you or perhaps a loved one particular suffered a severe bleeding occasion after taking Xarelto, you might have legal recourse. For a lot more data, get in touch with us right now to have your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in situations of death, funeral costs. Moreover, they're in search of punitive damages, that are usually awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for a lot more data on the alleged health risks of xarelto class of drug.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.